Loading clinical trials...
Loading clinical trials...
A Phase I Study of Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer as First-line Treatment
Conditions
Interventions
Ixabepilone, 32 mg/m^2 + Carboplatin, 5 mg/min/mL
Ixabepilone, 32 mg/m^2 + Carboplatin, 6 mg/min/mL
Locations
1
Japan
Local Institution
Chuo-Ku, Tokyo, Japan
Start Date
June 1, 2008
Primary Completion Date
September 1, 2009
Completion Date
September 1, 2009
Last Updated
March 10, 2016
NCT06305754
NCT05920356
NCT06128551
NCT07251582
NCT01720836
NCT06567015
Lead Sponsor
R-Pharm
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions